SARS-CoV-2 Omicron
Omicron, the latest SARS-CoV-2 variant of concern is characterized by a large number of mutations. Here we evaluate the effect of these mutations on T-cell immunity by applying a T-cell receptor (TCR)/epitope interaction model.
White papers
Reverse vaccinology
With the impending threats of antibiotic- resistant bacterial infections and future pandemics, implementing a fast and scalable vaccine development process is more urgent than ever. Reverse vaccinology is a computational vaccine-target identification method with stark benefits over traditional vaccine development. With a highly efficient pipeline, this bioinformatic technique allows for faster, safer, and cheaper vaccine development.
Find out more about reverse vaccinology in this white paper.
Connect with us!
Business [at] immunewatch.com
Copyright © 2021 ImmuneWatch BV. ImmuneWatch is a registered trademark.
ImmuneWatch BV | BE0774.472.942 | Lange Gasthuisstraat 29-31, 2000, Antwerp, Belgium